Cardiff Scintigraphics Ltd (CSL), is an established independent provider of gamma scintigraphy services to global pharma and medical device companies. Our specialised imaging services enable clinical evaluations of pharmaceutical formulations and devices. Established more thanCardiff Scintigraphics Ltd (CSL)
30 years ago, CSL has extensive experience in the design, conduct, analysis, interpretation and reporting of scintigraphy studies. CSL has built a wealth of knowledge in this field and has provided support for more than 30 different pharma companies including half of the
‘Global Top 10’.
Board of Directors
Andrew Brown, PhD
CEO
30 years experience in Product Development, and Device Development at GSK, Oriel and OBG
John Pritchard PhD
Chairman
Expert in Inhalation R&D and launch of Respiratory Products at GSK, 3M and Phillips Healthcare
Professor Glyn Taylor, PhD
CSO (Founding Director)
40 years experience in Inhalation Product Development and Clinical PK Studies at Cardiff University and i2C
Simon Warren, PhD
Research Director
30 years experience in Formulation and Clinical Imaging of Inhalation Products at i2C
Rhodri Turner, PhD
Non-Executive Director
15 years experience in Research Commercialization and Technology Transfer at Cardiff University
What We Offer
Well-Established
We have been working in inhalation and Medical Devices for more than
30 years
Innovation
Experts at providing innovative solutions to customer technical challenges. Have developed IP in the MDI field
Technical Expertise
Experts in Gamma Scintigraphy and MDI development with over 30 publications
Customer Focused
Provide responsive and flexible project management to support customers to achieve challenging timelines
Mission Statement
We help scientists and healthcare professionals see more clearly by providing high-quality imaging and analysis tools. Our goal is to make complex data easy to understand and use.
Vision Statement
To become a leading partner in pharmaceutical development by delivering clear, accurate imaging and analysis that support smarter decisions, faster innovation, and better patient outcomes.
